Cargando…

Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes

AIMS/HYPOTHESIS: Type 2 diabetes is characterised by reduced beta cell mass (BCM). However, it remains uncertain whether the reduction in BCM in type 2 diabetes is due to a decrease in size or number of beta cells. Our aim was to examine the impact of beta cell size and number on islet morphology in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki, Hironobu, Saisho, Yoshifumi, Inaishi, Jun, Watanabe, Yuusuke, Tsuchiya, Tami, Makio, Masayoshi, Sato, Midori, Nishikawa, Masaru, Kitago, Minoru, Yamada, Taketo, Itoh, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245378/ https://www.ncbi.nlm.nih.gov/pubmed/33938968 http://dx.doi.org/10.1007/s00125-021-05467-7

Ejemplares similares

Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults
por: Sasaki, Hironobu, et al.
Publicado: (2020)

Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study
por: Inaishi, Jun, et al.
Publicado: (2022)

Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas
por: Inaishi, Jun, et al.
Publicado: (2016)

Ethnic Similarities and Differences in the Relationship between Beta Cell Mass and Diabetes
por: Inaishi, Jun, et al.
Publicado: (2017)

Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
por: Sasaki, Hironobu, et al.
Publicado: (2021)

Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review
por: Inaishi, Jun, et al.
Publicado: (2020)

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
por: Watanabe, Yuusuke, et al.
Publicado: (2019)

Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
por: Saisho, Yoshifumi
Publicado: (2014)

Association of visit‐to‐visit glycemic variability with risk of cardiovascular diseases in high‐risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial
por: Sato, Midori, et al.
Publicado: (2021)

Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited
por: Saisho, Yoshifumi
Publicado: (2019)

Association of glucose tolerance status with pancreatic β‐ and α‐cell mass in community‐based autopsy samples of Japanese individuals: The Hisayama Study
por: Inaishi, Jun, et al.
Publicado: (2020)

Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
por: Inaishi, Jun, et al.
Publicado: (2022)

Longitudinal changes in pancreatic volume and pancreatic fat with weight gain in Japanese without diabetes: An analysis using health check-up data
por: Sunouchi, Maria, et al.
Publicado: (2023)

Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case report
por: Sasaki, Hironobu, et al.
Publicado: (2022)

Beta cell adaptation to pregnancy requires prolactin action on both beta and non-beta cells
por: Shrivastava, Vipul, et al.
Publicado: (2021)

Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function
por: Liu, Teng, et al.
Publicado: (2017)

Beta-cell Insufficiency
por: Kalra, Sanjay, et al.
Publicado: (2017)

IL-13 improves beta-cell survival and protects against IL-1beta-induced beta-cell death
por: Rütti, Sabine, et al.
Publicado: (2015)

Ecological stoichiometry influences phytoplankton alpha and beta diversity rather than the community stability in subtropical bay
por: Xu, Qiangsheng, et al.
Publicado: (2022)

Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2011)

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes
por: Saisho, Yoshifumi
Publicado: (2016)

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.
por: Damstrup, L., et al.
Publicado: (1993)

Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys
por: Saisho, Y., et al.
Publicado: (2009)

Beta Cell Count Instead of Beta Cell Mass to Assess and Localize Growth in Beta Cell Population following Pancreatic Duct Ligation in Mice
por: Chintinne, Marie, et al.
Publicado: (2012)

Role of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes
por: Wang, Hong-Lian, et al.
Publicado: (2022)

Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2012)

Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2012)

Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2012)

Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype
por: Martens, Geert A., et al.
Publicado: (2012)

The Beta Cell in Its Cluster: Stochastic Graphs of Beta Cell Connectivity in the Islets of Langerhans
por: Striegel, Deborah A., et al.
Publicado: (2015)

Innate and adaptive immunity to human beta cell lines: implications for beta cell therapy
por: van der Torren, Cornelis R., et al.
Publicado: (2015)

Clinical utility of 1‐month postpartum random plasma glucose and glycated hemoglobin combined with pre‐pregnancy body mass index for detecting postpartum glucose intolerance in Japanese women with gestational diabetes
por: Sugiyama, Kazutoshi, et al.
Publicado: (2021)

Increased urinary beta 2-microglobulin in cadmium exposure: dose-effect relationship and biological significance of beta 2-microglobulin.
por: Tsuchiya, K, et al.
Publicado: (1979)

Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study
por: Ishimwe, M C Sage, et al.
Publicado: (2021)

Beta-aluminas and beta batteries
por: Staikov, G
Publicado: (1991)

From bugs to beta cells
por: Zhang, Yuxi, et al.
Publicado: (2016)

Apoptotic Death of Beta-Cells
por: Žanić-Grubišić, Tihana
Publicado: (2002)

Heterogeneity of the Pancreatic Beta Cell
por: Gutierrez, Giselle Dominguez, et al.
Publicado: (2017)

The Pancreatic Beta Cell: Editorial
por: Bartolomé, Alberto
Publicado: (2023)

Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy
por: Butler, A. E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2bq2hsmdjpird0e4pnqgfugjmv